Status:
COMPLETED
Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Platelet Transfusion
Hematological Malignancy
Eligibility:
All Genders
18-100 years
Brief Summary
Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in tho...
Eligibility Criteria
Inclusion
- major patient
- patient with advanced hematological malignancies
- patient transfused in platelet regularly (3 time at least in last month)
- medical practioner, hematologist, prescribing platelet transfusion at least one per week.
- nurse working in hematology, practicing platelet transfusion at lest one peer week.
Exclusion
- minor patient
- non communicant patient
- non transfused platelet patient
- non voluntary patient or hematologist or nurses
- non graduated hematologist
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2019
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03806712
Start Date
April 1 2019
End Date
July 22 2019
Last Update
July 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moracchini
Besançon, France, 25000